Invitris

📍 Munich, Germany👥 20 employees💰 Last funded May 2023
Biotechnology🌐 invitris.com
Website LinkedIn
Our patent-pending biotech platform, Phactory, makes designing synthetic proteins 10,000x more effiicent and reduces the material costs by 100x. We are leveraging Phactory to develop the newest classes of protein-based drugs, such as the next generation of antibiotics.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
2
Brazil
1
Frequently asked questions
Who invested in Invitris?
Invitris has 3 investors on record on gritt.io.
When did Invitris last raise funding?
The most recent investment in Invitris recorded on gritt.io was in May 2023.
What industry is Invitris in?
Invitris operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Invitris based?
Invitris is headquartered in Munich, Germany.